ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Clinical trials for ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER explained in plain language.
Never miss a new study
Get alerted when new ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER trials appear
Sign up with your email to follow new studies for ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill shows promise against tough lung and brain cancers
Disease control OngoingThis study tests an experimental daily pill, BDTX-1535, in about 200 adults with advanced non-small cell lung cancer or glioblastoma (a type of brain tumor). The drug targets specific EGFR mutations that make cancers resistant to other treatments. The goal is to find the safest d…
Matched conditions: ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Phase: PHASE1, PHASE2 • Sponsor: Black Diamond Therapeutics, Inc. • Aim: Disease control
Last updated May 26, 2026 08:29 UTC
-
Scientists test if Real-World records can replace traditional cancer trials
Knowledge-focused OngoingThis study looks at medical records from over 800 people with advanced lung cancer to see if they can produce the same results as two earlier clinical trials. The goal is to learn when and how to use real-world data confidently for future research. Participants are not receiving …
Matched conditions: ADVANCED NON-SMALL CELL SQUAMOUS LUNG CANCER
Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated May 22, 2026 13:52 UTC